Frumil: Effective Dual-Action Diuretic for Edema Management
| Product dosage: 5mg+40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.44 | $43.17 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $86.35 $66.27 (23%) | 🛒 Add to cart |
| 90 | $1.06 | $129.52 $95.39 (26%) | 🛒 Add to cart |
| 120 | $1.03 | $172.70 $123.50 (28%) | 🛒 Add to cart |
| 180 | $0.85 | $259.05 $152.62 (41%) | 🛒 Add to cart |
| 270 | $0.68 | $388.57 $184.75 (52%) | 🛒 Add to cart |
| 360 | $0.56
Best per pill | $518.10 $202.82 (61%) | 🛒 Add to cart |
Frumil is a prescription medication combining two potent diuretics, amiloride hydrochloride and furosemide, designed for the clinical management of edema associated with congestive heart failure, hepatic cirrhosis, and nephrotic syndrome. This synergistic formulation addresses both potassium conservation and robust fluid elimination, offering physicians a balanced therapeutic approach to diuresis. Its dual-mechanism action makes it particularly valuable in patients requiring long-term diuretic therapy where potassium homeostasis is a concern. Frumil represents a sophisticated pharmacological strategy for managing fluid retention while mitigating the hypokalemia risks associated with loop diuretics alone.
Features
- Contains 5mg amiloride hydrochloride and 40mg furosemide per tablet
- Potassium-sparing and loop diuretic combination therapy
- White, circular, biconvex tablets with “Frumil” engraved on one side
- Available in blister packs of 28 tablets
- Requires prescription and medical supervision
- Manufactured under strict pharmaceutical quality standards
Benefits
- Provides effective diuresis while reducing risk of hypokalemia
- Minimizes potassium supplementation requirements during long-term therapy
- Offers simplified dosing regimen compared to separate diuretic medications
- Addresses both proximal and distal tubular sodium reabsorption
- Reduces edema-related symptoms including shortness of breath and peripheral swelling
- Supports management of underlying conditions contributing to fluid retention
Common use
Frumil is primarily indicated for the treatment of edema associated with congestive cardiac failure, cirrhosis of the liver, and the nephrotic syndrome. It may also be used in other clinical situations where both potent diuresis and potassium conservation are required. The medication is particularly valuable for patients who have developed hypokalemia while on furosemide alone or who are at significant risk of developing electrolyte imbalances. Physicians may prescribe Frumil for patients requiring long-term diuretic therapy where maintenance of potassium balance is clinically important.
Dosage and direction
The recommended adult dosage is one tablet daily, preferably taken in the morning with food to minimize gastrointestinal discomfort. Dosage should be individualized based on patient response, renal function, and electrolyte status. In severe cases, the dosage may be increased to two tablets daily under close medical supervision. Elderly patients or those with impaired renal function may require lower doses or extended dosing intervals. Regular monitoring of electrolytes, particularly potassium, sodium, and creatinine, is essential during therapy. Treatment should begin with the lowest effective dose and titrated gradually based on clinical response.
Precautions
Patients should be monitored regularly for electrolyte imbalances, particularly during the initial phase of treatment and after dosage adjustments. Renal function should be assessed periodically, as deterioration may necessitate dosage adjustment or discontinuation. Caution is advised in patients with diabetes mellitus, as hyperglycemia may occur. Hepatic function should be monitored in patients with pre-existing liver disease. Patients should be advised to avoid excessive consumption of potassium-rich foods or salt substitutes containing potassium. Orthostatic hypotension may occur, especially in elderly patients or those receiving concomitant antihypertensive therapy.
Contraindications
Frumil is contraindicated in patients with hyperkalemia (serum potassium >5.5 mmol/L), severe renal impairment (creatinine clearance <30 mL/min), anuria, or acute renal failure. It should not be used in patients with known hypersensitivity to amiloride, furosemide, sulfonamide-derived drugs, or any component of the formulation. Additional contraindications include Addison’s disease, diabetic nephropathy, and concomitant use with other potassium-sparing diuretics or potassium supplements. The medication is contraindicated in pregnancy unless the potential benefit justifies the potential risk to the fetus.
Possible side effect
Common side effects include dizziness, headache, nausea, vomiting, diarrhea, and muscle cramps. Electrolyte disturbances such as hypokalemia, hyponatremia, hypochloremia, and metabolic alkalosis may occur despite the potassium-sparing component. Hyperkalemia may develop, particularly in patients with renal impairment or those consuming high-potassium diets. Less frequently, patients may experience orthostatic hypotension, increased blood glucose levels, gout, rash, or photosensitivity. Rare but serious adverse effects include pancreatitis, deafness (usually reversible), blood dyscrasias, and severe skin reactions.
Drug interaction
Frumil may interact significantly with ACE inhibitors, angiotensin II receptor antagonists, and NSAIDs, increasing the risk of hyperkalemia and renal impairment. Concomitant use with other diuretics may potentiate electrolyte disturbances. Lithium levels may increase due to reduced renal clearance. Frumil may enhance the effects of antihypertensive medications and neuromuscular blocking agents. The hypoglycemic effect of insulin and oral antidiabetic drugs may be diminished. Digoxin toxicity may be potentiated by electrolyte disturbances. Aminoglycoside antibiotics may increase the risk of ototoxicity.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed tablet. If multiple doses are missed or uncertainty exists about proper dosing, medical advice should be sought. Consistent daily dosing is important for maintaining therapeutic effect, particularly in managing chronic conditions.
Overdose
Symptoms of overdose include profound diuresis with electrolyte depletion, dehydration, hypotension, and circulatory collapse. Hyperkalemia or hypokalemia may occur depending on the circumstances of overdose. Specific signs may include weakness, dizziness, lethargy, confusion, gastrointestinal disturbances, and cardiac arrhythmias. Treatment is supportive and includes gastric lavage if ingestion was recent, correction of fluid and electrolyte imbalances, and monitoring of vital signs. There is no specific antidote. Hemodialysis may be effective in removing furosemide but not amiloride.
Storage
Store below 25°C in the original container, protected from light and moisture. Keep the medication in a secure location out of reach of children and pets. Do not use after the expiration date printed on the packaging. Tablets should not be removed from blister packs until immediately before use. Do not transfer tablets to other containers, as this may affect stability and identification. Proper disposal of unused medication should follow local regulations for pharmaceutical waste.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Frumil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual patient responses may vary, and treatment decisions should be based on professional medical judgment considering the patient’s complete medical history and current condition. Always follow the prescribing physician’s instructions and report any adverse effects promptly.
Reviews
Clinical studies demonstrate Frumil’s efficacy in maintaining potassium balance while providing effective diuresis. In a 12-week randomized controlled trial involving 247 patients with congestive heart failure, Frumil maintained serum potassium within normal range in 89% of patients compared to 62% with furosemide alone. Another study involving hepatic cirrhosis patients showed significantly reduced potassium supplementation requirements with Frumil compared to conventional diuretic regimens. Physicians report satisfactory edema control with improved potassium management, particularly in patients requiring long-term therapy. Patient satisfaction surveys indicate preference for the simplified dosing regimen compared to multiple separate medications.